Stanford Researchers have discovered fluorinated acetal electrolytes for lithium metal batteries that demonstrate fast stabilization of lithium metal, compatibility with high-voltage cathodes, and low cell impedance.
Researchers at Stanford University have developed a bespoke method for multiplexing beads in bioassays that expands the possible coding space when compared to available bead barcoding technologies.
Stanford researchers have solved the Cryo-EM structure of a powerful new optogenetic actuator, ChRmine, and have successfully used structure guided design to create three new proteins: rsChRmine, hsChRmine and hs/rs ChRmine, conferring red-shifted, high-speed and a combination
Despite their cytotoxic capacity, neutrophils are often co-opted by cancers to promote immunosuppression, tumor growth, and metastasis. Consequently, these cells have received little attention as potential cancer immunotherapeutic agents.
Researchers at Stanford University have discovered a new type of integrin-mediated cell adhesion, called curved adhesion, that represents the dominant structure in 3D physiological environments.
Researchers at Stanford have invented a novel hydrogel with enhanced retention and extended durability. This hydrogel can be held together three times longer than many alternatives without sacrificing its self-healing attributes during injection.
Researchers at Stanford University have developed an affinity capture technique for top-down protein analysis that directly couples biolayer interferometry (BLI) with high resolution mass spectrometry (HR-MS).
Targeted protein degradation is an emerging strategy for the elimination of classically undruggable proteins. Mucins are known to be involved in tumor-progressive pathways but are difficult to target using small molecules and antibodies.
Stanford researchers have made a genetic mouse model to mimic the human LOXHD1 p.R1090Q mutation as a means to further investigate, understand and combat human Age-Related Hearing Loss (ARHL).
Researchers in the Burns group at Stanford designed a reaction methodology that allows for a green and inexpensive cycloaddition of amine or amide-containing unactivated olefins for the synthesis of biologically relevant cyclobutanes.
Stanford researchers have invented a method and developed compositions of matter to reduce the production of infectious viruses in cells that line the respiratory tract. The invention enables the use of gene-silencing approaches to prevent and treat viral infections.
Stanford researchers have developed a new controllable methodology for molecularly targeted ultrasound contrast agent production with pre-formed ligand-phospholipid bioconjugates.